𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Symptomatic hypokalemia associated with infliximab in a patient with Crohn's disease

✍ Scribed by George Karamanolis; Charalambos Tzathas; Konstantinos Triantafyllou; Zaharias Tsiamoulos; Spiros Ladas


Book ID
110087436
Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
85 KB
Volume
12
Category
Article
ISSN
1078-0998

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Salmonella septic arthritis in a patient
✍ Jean Y. Rim; Allan R. Tenorio πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 56 KB πŸ‘ 2 views

The use of tumor necrosis factor a (TNFa) inhibitors such as infliximab, etanercept, and adalimumab for various autoimmune diseases, including Crohn's disease (CD) and ulcerative colitis (UC), has increased in the past few years. While associated with symptomatic relief in many patients, the use of